Memorial Sloan Kettering Symposium on Lymphoma · 2016-04-25 · Is pleased to announce:...

Is pleased to announce:

Friday-Saturday, May 13-14, 2016

Memorial Sloan Kettering Symposium on LymphomaState of the art in biology, therapy, and patient care

CONFERENCE LOCATION

MEMORIAL SLOAN KETTERING CANCER CENTERZUCKERMAN RESEARCH CENTER

NEW YORKTo register or for more information, please go to:

www.mskcc.org/lymphoma2016


Memorial Sloan Kettering Symposium on Lymphoma


State of the art in biology, therapy, and patient care

TARGET AUDIENCEMedical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in diagnosis, treatment, and biomedical research of lymphoma.

COURSE OVERVIEWThis symposium will feature updated information on lymphoma biology, diagnosis, immunology, and genetics, and ongoing efforts to translate the scientific discoveries into novel treatment strategies for a variety of lymphomas. Faculty will review the current standard of care and present their own perspectives on how they treat various types of lymphomas. Participants will have the opportunity to discuss diagnostic and management cases, and how to incorporate biologic and genetic biomarkers into clinical practice and clinical trials.

You won't want to miss this unprecedented symposium focused on the future of Lymphoma with many of

the world’s leading experts.




SYMPOSIUM CHAIR

Anas Younes MD Chief, Lymphoma Service

ORGANIZING COMMITTEE

Ahmet Dogan MD PhD

Craig Moskowitz MD

Hans Guido Wendel MD

Joachim Yahalom MD FACR

Andrew Zelenetz MD PhD



www.mskcc.org/lymphoma2016 www.mskcc.org/lymphoma2016

MSK FACULTY GUEST FACULTY

Maria Arcila MDConnie Batlevi MD PhDJohn F. Gerecitano MD PhDPaul Hamlin MDSteven Horwitz MDAndrew M. Intlekofer MD PhDAnita Kumar MDMatthew Matasar MDAlison Moskowitz MDAriela Noy MDM. Lia Palomba MDCarol Portlock MDMikhail Roshal MDMichel Sadelain MD PhDDavid Straus MDJedd D. Wolchok MD PhD

Ranjana Advani MDStanford University

Steve Ansell MD PhDMayo Clinic

Francesco D’Amore MDAarhus University

Riccardo Dalla-Favera MDColumbia University

Martin Dreyling MDLudwig Maximilian University

Randy Gascoyne MDBC Cancer Agency

Elaine Jaffe MDNational Cancer Institute

Ronald Levy MDStanford University

Barbara Pro MDNorthwestern University

John Radford MDUniversity of Manchester

Louis Staudt MD PhDNational Cancer Institute

Gilles Salles MD PhDHospices Civils de Lyon

Wyndham Wilson MD PhDNational Cancer Institute

Thomas Witzig MDMayo Clinic

MSK conducts one of thelargest clinical researchprograms in the world,aimed at improving the

prevention, diagnosis,and treatment of cancer.

In December 2013, ourphysicians were leading

1,259 clinical researchstudies for pediatric

and adult cancers.






GUEST FACULTY

Ranjana Advani MDStanford University

Steve Ansell MD PhDMayo Clinic

Francesco D’Amore MDAarhus University

Riccardo Dalla-Favera MDColumbia University

Martin Dreyling MDLudwig Maximilian University

Randy Gascoyne MDBC Cancer Agency

Elaine Jaffe MDNational Cancer Institute

Ronald Levy MDStanford University

Barbara Pro MDNorthwestern University

John Radford MDUniversity of Manchester

Louis Staudt MD PhDNational Cancer Institute

Gilles Salles MD PhDHospices Civils de Lyon

Wyndham Wilson MD PhDNational Cancer Institute

Thomas Witzig MDMayo Clinic

Friday, May 137:00-8:00am BREAKFAST & REGISTRATION

8:00-8:05am Welcoming Remarks and Introduction to the MSK Lymphoma Symposium and Grand Rounds Lecture Anas Younes MD

8:05-8:50am DEPARTMENT OF MEDICINE GRAND ROUNDS Advances in Immunotherapy of Lymphoma Ronald Levy MD

INTRODUCTION CHAIRS Anas Younes MD and Elaine Jaffe MD

9:15-9:45am LymphomaClassification Elaine Jaffe MD

9:45-10:15am Advances in Molecular Diagnostics Maria Arcila MD

10:15-10:35am Advances in Radiation Oncology Joachim Yahalom MD FACR

10:35-10:50am Survivorship Program for Patients with Lymphoma Matthew Matasar MD

10:50-11:30am State of The Lymphoma at MSK Anas Younes MD

11:30am-12:30pm LUNCH

DIFFUSE LARGE B CELL LYMPHOMA-I CHAIRS Louis Staudt MD PhD and Thomas Witzig MD

12:30-12:45pm DLBCL Overview Thomas Witzig MD

12:45-1:15pm Advances in DLBCL Biology Riccardo Dalla-Favera MD

1:15-1:45pm Mechanism-Based Therapy of Lymphoma Louis Staudt MD PhD

1:45-2:05pm Application of Genome Sequencing in Hematopathology Practice Ahmet Dogan MD PhD

2:05-2:20pm How I Treat DLBCL Andrew Zelenetz MD PhD

2:20-2:35pm How I Treat Double Hit Lymphoma Wyndham Wilson MD PhD

2:35-2:50pm How I Treat Burkitt Lymphoma Ariela Noy MD

2:50-3:15pm CLINICAL CASES CHAIRS Witzig, Zelenetz, Wilson, Hamlin, Noy, Jaffe

3:15-3:30pm BREAK



www.mskcc.org/lymphoma2016 www.mskcc.org/lymphoma2016

Friday, May 13HODGKIN LYMPHOMA CHAIRS John Radford MD and Craig Moskowitz MD

3:30-4:00pm HL Overview John Radford MD

4:00-4:30pm Advances in HL Biology Randy Gascoyne MD

4:30-4:45pm HL Genetics Mikhail Roshal MD

4:45-5:00pm How I Treat Newly Diagnosed HL David Straus MD

5:00-5:15pm How I Treat Relapsed HL Craig Moskowitz MD

5:15-5:30pm Novel Therapy for Hodgkin Lymphoma Alison Moskowitz MD

5:30-6:00pm CLINICAL CASESCHAIRS Radford, Moskowitz, Younes, Ansell, Straus, Yahalom, Gascoyne

6:00-7:00pm COCKTAIL RECEPTION






Friday, May 13 HODGKIN LYMPHOMA

CHAIRS John Radford MD and Craig Moskowitz MD

3:00-3:30pm HL Overview John Radford MD

3:30-4:00pm Advances in HL Biology Randy Gascoyne MD

4:00-4:15pm HL Genetics Mikhail Roshal MD

4:15-4:30pm How I Treat Newly Diagnosed HL David Straus MD

4:30-4:45pm How I Treat Relapsed HL Craig Moskowitz MD

4:45-5:00pm Novel Therapy for Hodgkin Lymphoma Alison Moskowitz MD

5:00-5:30pm CLINICAL CASES CHAIRS Radford, Moskowitz, Younes, Ansell, Straus, Yahalom, Gascoyne

5:30-6:30pm COCKTAIL RECEPTION

Saturday, May 147:00-8:00am BREAKFAST

FOCUS ON IMMUNO ONCOLOGY CHAIRS Ronald Levy MD and Anas Younes MD

8:00-8:30am Overview of Immune Checkpoint Inhibitors in Cancer Jedd D. Wolchok MD PhD

8:30-9:00am Novel Immune Therapy Strategies Ronald Levy MD

9:00-9:30am Advances in CAR T cell Therapy Michel Sadelain

9:30-9:50am Immune Checkpoint Inhibitors in Lymphoma Steve Ansell MD PhD

9:50-10:10am NovelBispecificAntibodiesandADCs Ranjana Advani MD

10:10-10:30am Novel Immune Therapy Combinations Anas Younes MD

TRIALS IN PROGRESS CHAIRS Paul Hamlin MD and John Gerecitano MD PhD

10:30-10:40am Trials in Progress with Immune Checkpoint Inhibitors A. Moskowitz, Palomba

10:40-10:50am Trials in Progress with ADC Hamlin, Horwitz

10:50-11:00am Trials in Progress with BCL2 Inhibitors Zelenetz, Gerecitano

11:00-11:10am Trials in Progress with PI3K Inhibitors Horwitz, Gerecitano

11:10-11:20am Trials with Biomarker Selection (CREBBP IDH2, EZH2,MDM2) Intlekofer, Batlevi

11:20-11:30am Trials in Progress with BCR Signaling Inhibitors Noy, Hamlin

11:30-11:45am BREAK




Saturday, May 14T CELL LYMPHOMA CHAIRS F. D’Amore and S. Horwitz

11:45am-12:15pm T Cell Lymphoma Overview Francesco D’Amore MD

12:15-12:30pm How I Treat Newly Diagnosed PTCL Steven Horwitz MD

12:30-12:45pm How I Treat Patients with Relapsed T Cell Lymphoma Barbara Pro MD

12:45-1:00pm CLINICAL CASESCHAIRS Horwitz, D’Amore, Pro, Advani, Yahalom, Jaffe, Dogan

1:00-2:00pm LUNCH

MANTLE CELL AND FOLLICULAR LYMPHOMA CHAIRS Martin Dreyling MD and Gilles Salles MD PhD

2:00-2:30pm MCL Overview Martin Dreyling MD

2:30-3:00pm How I Treat MCL Paul Hamlin MD

3:00-3:30pm Follicular Lymphoma Overview Gilles Salles MD

3:30-4:00pm Insights into Follicular Lymphoma Biology Hans Guido Wendel MD

4:00-4:30pm EpigeneticModifiersinthePathogenesisofFollicular Lymphoma Laura Pasqualucci MD

4:30-5:00pm How I Treat Newly Diagnosed Indolent Lymphoma Carol Portlock MD

5:00-5:15pm How I Treat Waldenstrom Macroglobulinemia M. Lia Palomba MD

5:15-5:45pm CLINICAL CASESCHAIRS Dreyling, Salles, Portlock, Gascoyne, Dogan

5:45pm CLOSING REMARKSAnas Younes MD



Saturday, May 14 T CELL LYMPHOMA

CHAIRS F. D’Amore and S. Horwitz

11:45am-12:15pm T Cell Lymphoma Overview Francesco D’Amore MD

12:15-12:30pm How I Treat Newly Diagnosed PTCL Steven Horwitz MD

12:30-12:45pm How I Treat Patients with Relapsed T Cell Lymphoma Barbara Pro MD

12:45-1:00pm CLINICAL CASES CHAIRS Horwitz, D’Amore, Pro, Advani, Yahalom, Jaffe, Dogan

1:00-2:00pm LUNCH

MANTLE CELL AND FOLLICULAR LYMPHOMA CHAIRS Martin Dreyling MD and Gilles Salles MD PhD

2:00-2:30pm MCL Overview Martin Dreyling MD

2:30-3:00pm How I Treat MCL Paul Hamlin MD

3:00-3:30pm Follicular Lymphoma Overview Gilles Salles MD

3:30-4:00pm Insights into Follicular Lymphoma Biology Hans Guido Wendel MD

4:00-4:30pm EpigeneticModifiersinthePathogenesisofFollicular Lymphoma Laura Pasqualucci MD

4:30-5:00pm How I Treat Newly Diagnosed Indolent Lymphoma Carol Portlock MD

5:00-5:15pm How I Treat Waldenstrom Macroglobulinemia M. Lia Palomba MD

5:15-5:45pm CLINICAL CASES CHAIRS Dreyling, Salles, Portlock, Gascoyne, Dogan

5:45pm CLOSING REMARKS Anas Younes MD

REGISTRATION

$400 MDs, PhDs, DOs

$280 MSK Alliance and MSK Alumni

$200 Nurses, PAs, and other Healthcare Professionals

$100 Residents and Fellows

Registration includes continental breakfast, lunch, and refreshment breaks. Special meals are available upon request, including vegetarian, kosher, or gluten-free. Please let us know if we can assist you with any special dietary needs.

To register, please go to:

www.mskcc.org/lymphoma2016The registration fee is waived for all MSK staff. However, you must register for the course by visiting the Continuing Medical Education page on OneMSK

OFFICE OF CONTINUING MEDICAL EDUCATIONMemorial Sloan Kettering Cancer Center633ThirdAvenue,12thfloor,NewYork,[email protected]

COURSE DESIGN

This symposium includes hands-on review of cases which will be intermixed with short didactic lectures. One workstation per participant.

EVALUATION

A course evaluation survey sent out electronically will provide attendees with the opportunity to review the sessions and the speakers and to identify future educational needs.

ACCREDITATION STATEMENT

MSK is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENT

MSK designates this live activity for a maximum of 17.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. The AMA has determined that physicians not licensed in the United States but who participate in this CME activity are eligible for 17.25 AMA PRA Category 1 Credits™.

OUTCOMES MEASUREMENT SURVEY

Six months after the end of the course an Outcomes Measurement Survey will be sent to all participants to help us determine what positive impacts have been made on participant practice as a result of the course.

FACULTY DISCLOSURE

It is the policy of MSK to make every effort to insure balance, independence, objectivity,andscientificrigorinallcontinuing medical education activities which it sponsors as an ACCME accredited provider. In accordance with ACCME guidelines and standards, all faculty participating in an activity sponsored by MSK are expected todiscloseanysignificantfinancialinterest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services which are discussed by the faculty members in an educational presentation. As required by the ACCME, when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, MSK requires the speaker to disclose that the product is not labeled for the use under discussion or that the product is still investigational.

ACCOMMODATIONS

If you are traveling to MSK from outof town, we recommend that youreserve hotel rooms as early aspossible. To make the planning a littleeasier, MSK has negotiated rates atselect hotels in Manhattan. For a list of these hotels, please go to:www.mskcc.org/accommodations.

Memorial Sloan Kettering Symposium on Lymphoma · 2016-04-25 · Is pleased to announce:...

Documents

Transcript of Memorial Sloan Kettering Symposium on Lymphoma · 2016-04-25 · Is pleased to announce:...